Elmiron side effects can cause vision-threatening complications, researchers warn, leading many long-term users to express concerns about why earlier warnings were not provided.
Doctors and consumers in the U.S. are still not being officially warned about Elmiron vision loss risks, despite such warnings being in place on Canadian labels since October 2019.
An Elmiron lawsuit claims the manufacturers failed to adequately warn patients and the medical community about the risks of vision loss.
A case study of an Elmiron maculopathy misdiagnosis highlights the need for doctors to check patient drug usage for potential medication-related side effects.
A case study warns that vision loss deterioration linked to Elmiron side effects can continue for years after use is discontinued.
